-
PurposeHygromycin resistance co-injection marker
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 190933 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepDONR1-2
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 2544
- Total vector size (bp) 4281
-
Vector typeWorm Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHygromycin resistance gene
-
Alt nameHygroR
-
SpeciesC. elegans (nematode)
- Promoter rps-0
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer M13F
- 3′ sequencing primer M13R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThe hygromycin resistance gene was originally developed by the Chin lab (Cambridge U) in the publication Radman et al. (2013) Plos One (https://pubmed.ncbi.nlm.nih.gov/24130756/).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The plasmid can be used as a co-injection marker to select for transgenic C. elegans using hygromycin B selection.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCFJ782 - HygroR was a gift from Christian Froekjaer-Jensen (Addgene plasmid # 190933 ; http://n2t.net/addgene:190933 ; RRID:Addgene_190933) -
For your References section:
Modular safe-harbor transgene insertion (MosTI) for targeted single-copy and extrachromosomal array integration in C. elegans. El Mouridi S, Alkhaldi F, Frokjaer-Jensen C. G3 (Bethesda). 2022 Jul 28. pii: 6651068. doi: 10.1093/g3journal/jkac184. 10.1093/g3journal/jkac184 PubMed 35900171